Q32 Bio to Participate in Upcoming September Investor Conferences
Ben Wolff and Trevor Thatcher will join a Jefferies fireside chat and two investor events, with webcast access for some sessions.
- On August 31, 2026, Palladyne AI announced that CEO Ben Wolff and CFO Trevor Thatcher will participate in two upcoming investor conferences this September.
- Based in Salt Lake City, the company develops embodied AI-powered collaborative autonomy solutions, advanced avionics, and precision-manufactured components for aerospace and defense sectors.
- Wolff will participate in a fireside chat at the Jefferies Global Industrials Conference on Wednesday, September 9, 2026, hosted by Jefferies analyst Adam Samuelson.
- Management will attend the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference, or "BIG10," on Thursday, September 10, 2026, for investor meetings.
- Palladyne AI aims to lead the industrial sector's transition from automation to autonomy by combining deep domain expertise with decades of global installed base data.
26 Articles
26 Articles
Herald & Review
stocktitan.netTETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP of Investor Relations, will be meeting with institutional investors at the…
Morgan County Citizen
inovio.comINOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in…
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will…
North Bay Nipissing
Financial PostProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming September 2026 conferences…
Coverage Details
Bias Distribution
- 68% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
